fls.txt
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about expected earnings, revenues, growth, liquidity or other financial matters.


item1.txt
The condensed consolidated balance sheets as of September 30, 2019 and December 31, 2018, the related condensed consolidated statements of income and condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2019 and 2018, and the related condensed consolidated statements of cash flow for the nine months ended September 30, 2019 and 2018 include the accounts of Amphenol Corporation and its subsidiaries (“Amphenol”, the “Company”, “we”, “our”, or “us”).
All material intercompany balances and transactions have been eliminated in consolidation.
The condensed consolidated financial statements included herein are unaudited.
In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation in conformity with accounting principles generally accepted in the United States of America have been included.
In accordance with Securities and Exchange Commission Release No.
Prior to adoption, the Company evaluated Topic 842, including the initial review of any necessary changes to existing processes and systems that would be required to implement this standard, in order to determine its impact on our consolidated financial statements and related disclosures.
In 2018, the Company implemented a new lease management system that facilitated the adoption of this standard and enabled the Company to fulfill its requirements for both reporting and disclosure purposes, as well as to better manage and monitor the Company’s ongoing lease portfolio.
On January 1, 2019, we adopted Topic 842 using the updated modified retrospective transition approach allowed under ASU 2018-11 and did not restate prior periods.
have a material impact on our Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2019 and our Condensed Consolidated Statements of Cash Flow for the nine months ended September 30, 2019, nor did it have any impact on our compliance with debt covenants.
The adoption of Topic 842 provided various optional practical expedients in transition, some of which we have elected.
Refer to Note 15 herein for further details regarding the impact of the adoption of Topic 842 and other information related to our lease portfolio.
While the Company typically offers standard product warranty coverage which provides assurance that our products will conform to the contractually agreed-upon specifications for a limited period from the date of shipment, the Company’s warranty liabilities as of September 30, 2019 and December 31, 2018, and related warranty expense for the three and nine months ended September 30, 2019 and 2018 have not been and were not material in the accompanying Condensed Consolidated Financial Statements.
During the three and nine months ended September 30, 2019, the Company repurchased 1.7 million and 6.1 million shares of its Common Stock for $150.0 and $558.7, respectively, under the 2018 Stock Repurchase Program.
The Company has not repurchased any additional shares of its Common Stock from October 1, 2019 to October 22, 2019, and has remaining authorization to purchase up to $888.1 of its Common Stock under the 2018 Stock Repurchase Program.
During the three months ended March 31, 2018, the Company repurchased 4.2 million shares of its Common Stock for $382.0 under the 2017 Stock Repurchase Program, bringing total repurchases under this program to 12.6 million shares or $1,000.0, thus completing the 2017 Stock Repurchase Program.
These repurchases in the first quarter of 2018, coupled with the Company’s repurchase of 3.5 million shares of its Common Stock for $298.2 under the 2018 Stock Repurchase Program during the six months ended September 30, 2018, resulted in total repurchases of 7.7 million shares for $680.2 during the nine months ended September 30, 2018.
On July 23, 2019, the Company’s Board of Directors approved an increase to its quarterly dividend rate from $0.23 to $0.25 per share effective with dividends declared in the third quarter of 2019.
Excluded from the computations above were anti-dilutive common shares of 12.2 million and 6.1 million for the three months ended September 30, 2019 and 2018, respectively.
The Company has been named as a defendant in several legal actions arising from normal business activities.
For the three months ended September 30, 2019 and 2018, the Company’s income before income taxes was reduced for stock-based compensation expense of $16.6 and $14.4, respectively.
For the nine months ended September 30, 2019 and 2018, the Company’s income before income taxes was reduced for stock-based compensation expense of $46.4 and $40.4, respectively.
Stock-based compensation expense includes the estimated effects of forfeitures, which are adjusted over the requisite service period to the extent actual forfeitures differ or are expected to differ from such estimates.
A committee of the Company’s Board of Directors has been authorized to grant stock options pursuant to the 2017 Employee Option Plan.
No additional stock options will be granted under the 2009 Employee Option Plan.
The 2004 Directors Option Plan expired in May 2014, except that its terms continue with respect to any outstanding options granted thereunder.
Options were last granted under the 2004 Directors Option Plan in May 2011. under the 2004 Directors Option Plan are fully vested and are generally exercisable over a period of ten years from the date of grant.


item2.txt



item3.txt
The Company may borrow under its Revolving Credit Facility and Commercial Paper Programs.


item4.txt
Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.


part2.txt
Item 1.


